检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Rationale and design of three ongoing phase 1/2 trials of modakafusp alfa, an innate immunity enhancer, in patients with multiple myeloma: The innovate clinical development program

Hira Mian,Cyrille Touzeau,Sarah Holstein,Edwin Kingsley,Dan Vogl,Richard Zuniga,Kihyun Kim,Kaveri Suryanarayan,Shining Wang,Laura Thesillat-Versmee,Yuyin Liu,Tian Chen, Yefei Zhang,Xavier Parot,Hans Lee

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）

引用 0|浏览3
暂无评分
关键词
multiple myeloma,innate immunity enhancer,modakafusp alfa
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要